Citations 11
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery
Grossman, Stuart A. , Romo, Carlos G. , Supko, Jeffrey G. , Fisher, Joy , Wen, Patrick Y. , Elmquist, William F. , Barker, Fred G., Timmer, William C., Ye, Xiaobu , Grossman, Stuart A , Romo, Carlos , Rudek, Michelle A. , Nabors, Burt , Wen, Patrick Yung , Peereboom, David M. , Ellingson, Benjamin M. , Kamson, David , Sarkaria, Jann N. , Bindra, Ranjit S.
Neuro-Oncology | June 2, 2020 | Volume: 22 | Issue: 10 | Pages: 1422-1424
